Background. -Assessment of health-related quality of life is widely recommended by European health agencies in relevant research studies as well as in clinical care. Aims. -To validate the French version of the MacNew heart disease health-related quality of life questionnaire. Methods. -As part of the International HeartQoL Project, 323 French-speaking patients with ischaemic heart disease (angina, n = 76; myocardial infarction [MI], n = 155; heart failure, n = 91; mean age 58.6 ± 11.3 years) were recruited at seven cardiac rehabilitation centres. All patients completed the French versions of the MacNew questionnaire, the Short Form-36 Health Survey (SF-36) and the Hospital Anxiety and Depression Scale, to evaluate the psychometric properties of the French version of the MacNew instrument.
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Quality of life; MacNew questionnaire; French version; Ischaemic heart disease Introduction Traditionally, outcomes of existing and new therapies have been focused on mortality and morbidity. However, in addition to mortality and morbidity, agencies such as the European Medicines Agency [1] and the US Food and Drug Administration [2] recommend the use of patient-centred outcome measures, such as health-related quality of life (HRQL), in relevant research studies as well as in clinical care. This recommendation is supported by the National Heart, Lung and Blood Institute [3] and the American Heart Association [4] in patients with cardiovascular disease, and a recent report by the French Health Authority also supports the use of patient-centred outcome measures, especially in patients with myocardial infarction (MI) [5] . The two basic formats for HRQL questionnaires -generic and diseasespecific instruments -are designed for different purposes. Generic HRQL questionnaires are designed to assess a wide range of health states, while specific HRQL questionnaires, with a focus on disease-relevant issues, are appropriate outcome measures in both therapeutic intervention trials and routine clinical care [6, 7] . However, specific HRQL questionnaires should be used only in patients with the diagnosis for which the instrument is validated and not with an 'off-label diagnosis'.
Marked health status deficits, including poor HRQL, are frequently seen in patients with ischaemic heart disease (IHD) [3] . Treatments such as medications, interventions and rehabilitation in patients with angina, MI and heart failure have common therapeutic goals that include symptom management and improvement of HRQL. Across-diagnosis HRQL treatment outcome comparisons within a disease are not possible with a diagnosis-specific HRQL questionnaire and require the use of either a generic HRQL questionnaire or, alternatively, a core HRQL questionnaire validated in each diagnosis. Core HRQL questionnaires have been standard practice for 20 years or more in oncology [8] , where across-diagnosis treatment comparisons are possible, allowing an understanding of the range of HRQL across diagnoses.
Comparisons across diagnoses such as angina, MI and heart failure should not be made with an IHD diagnosisspecific HRQL tool. For example, the Seattle Angina Questionnaire item stem refers specifically to 'chest pain, chest tightness or angina' [9] , while the Minnesota Living with Heart Failure questionnaire [10] item stem refers specifically to 'your heart failure', precluding across-diagnosis comparisons. On the other hand, the selfadministered MacNew Heart Disease HRQL questionnaire uses an item stem that refers to 'your heart problem' [11] , allowing across-diagnosis comparisons. The MacNew questionnaire, a modification of the interviewer-administered Quality of Life after Myocardial Infarction questionnaire [12, 13] , was originally developed and validated in 724 English-speaking patients with MI [11, 14] . There are now 38 language versions of the MacNew questionnaire, with validation studies in patients with MI (n > 4000) in 13 languages, in patients with angina (n > 1800) in 12 languages and in patients with heart failure (n > 550) in 11 languages [15] .
Reliability, validity, responsiveness and interpretability are important psychometric properties of patient-reported outcome measures [16, 17] . As the MacNew questionnaire has not been validated in French-speaking patients with angina, MI or heart failure, the primary objectives of this study are to report the reliability and validity of the French version of the MacNew questionnaire in patients with IHD (regardless of the specific diagnosis), with angina, with MI and with heart failure.
Methods

Patients
French-speaking patients with IHD and a diagnosis of angina, MI or heart failure were recruited at seven centres (Strasbourg, Bligny Essonne, Dijon, Machecoul, Saint-Denis, Saint-Orens and Les Moulineaux) as part of the international HeartQoL Project [18] . The respective Institutional Review Boards approved the project and informed consent was obtained from all subjects.
A convenience sample of patients aged ≥ 18 years, without a documented psychiatric disorder or active substance abuse, who the referring physician considered able to complete the self-administered battery of HRQL instruments, were eligible if they were being treated for: angina (Canadian Cardiovascular Society class II, III or IV) with an objective measure of IHD (e.g. previous MI, exercise testing, echocardiogram, nuclear imaging or angiography); or MI diagnosed at least 4 weeks and < 6 months previously; or ischaemic heart failure (New York Heart Association [NYHA] class II, III or IV), with evidence of left ventricular dysfunction (ejection fraction ≤ 40% by invasive or non-invasive testing) and an objective measure of IHD (e.g. previous MI, exercise testing, echocardiogram, nuclear imaging or angiography).
Patient-centred outcome assessment
The referring physician provided routine clinical and diagnostic data and all patients completed a self-report sociodemographic and clinical questionnaire. The Short Form-36 Health Survey (SF-36), the Hospital Anxiety and Depression Scale (HADS) and the MacNew questionnaire were administered at baseline to all patients and 2 weeks later to approximately 20% of the patients for test-retest validation.
Short Form-36
The SF-36 is a validated generic health survey consisting of 36 items, with eight subscales summarized in a physical component summary (PCS) and a mental component summary (MCS), and has been used extensively internationally in clinical trials [19] .
Hospital Anxiety and Depression Scale
The HADS is a validated psychological screening instrument designed to detect symptoms of anxiety and depression; it has been used extensively internationally in clinical trials, with scores ≥ 8 used to classify patients with symptoms of depression or anxiety [20] .
MacNew questionnaire
The development of the MacNew instrument has been described previously [21] ; it is designed to assess a patient's feelings about how IHD affects daily functioning, and contains 27 items, with a global HRQL scale and physical limitation, emotional and social function subscales [11, 14] . The MacNew items and scales are scored from 1 (low HRQL) to 7 (high HRQL) and the minimal important difference (MID) on each MacNew scale is 0.50 points [22] . Using forward-backward translation, the MacNew questionnaire was translated into French as part of the international HeartQoL Project [18] . There is a licence fee for researchers and clinics who wish to use the French version of the Mac-New questionnaire (it is free to students). Information about licence fees is available at http://www.macnew.org.
Statistical analysis
Clinical, sociodemographic and scale characteristics Patient characteristics are described using frequencies and means ± standard deviations. Analysis of variance (continuous variables) and the Chi 2 test (categorical variables) were used to make comparisons between the three cardiac diagnostic groups. Floor and ceiling effects were determined at the lowest (1) and highest (7) scores.
Psychometric properties
The conceptual model, reliability and validity, as well as the interpretability and the respondent and administrative burden of the MacNew questionnaire, were assessed as recommended by the Scientific Advisory Committee of Medical Outcomes Trust [16] . Face and content validities of the Mac-New questionnaire have been established previously [15] .
Factor analysis
An exploratory principal component factor analysis with varimax rotation using factor loadings of ≥ 0.40 was conducted to allocate items to a scale in the French version of the MacNew questionnaire and to determine the degree to which this factor structure replicated the original.
Reliability
The reliability of the MacNew questionnaire was evaluated by examining its internal consistency (Cronbach's ␣); test-retest reliability (14-day) was assessed with intraclass correlation coefficient in a 20% target sample. A value of ≥ 0.70 was considered the criterion value for group comparisons and ≥ 0.90 for individual comparisons [16] .
Validity
We hypothesized strong correlations between the SF-36 PCS and MCS and the similar MacNew scale constructs, and lower correlations between dissimilar constructs (r < 0.20 = absent; 0.20-0.34 = weak; 0.35-0.49 = moderate; ≥ 0.50 = strong) as a test of construct validity [23] . We tested discriminative validity of the MacNew questionnaire using the 'known group' method [24] . We also examined the pattern of Mac-New scores hypothesizing poorer HRQL in congestive heart failure patients who reported perceived health status on the health transition item of the SF-36 collapsed in three groups (deteriorated, no change, improved) and, using the HADS cut-off scores of < 8 and ≥ 8, in patients with and without anxiety or depression symptoms.
Results
Patient characteristics
Baseline sociodemographic and clinical data were collected on 323 patients with IHD (angina, n = 76; MI, n = 156; heart failure, n = 91) who were recruited at seven centres in France ( Table 1 ). The mean age in the group as a whole was 58.6 ± 11.3 years; patients with angina (mean age 64.2 ± 8.5 years) were older than patients with either MI or HF (P < 0.001). Patients with angina were most likely to have high cholesterol (P = 0.002); patients with MI were most likely to be current smokers (P = 0.008) and to be physically inactive (P < 0.03); patients with heart failure were most likely to be hypertensive (P = 0.004). There were more patients with Canadian Cardiovascular Society angina class II (67.1%) than class III/IV (32.9%) and more patients with NYHA class II (57.1%) than class III/IV (42.9%).
Patient-centred outcome scores
MacNew questionnaire
Mean MacNew global scale scores were 4.9 ± 1.0 in the group as a whole and were higher in patients with MI than in patients with angina (5.0 ± 1.0 vs. 4.6 ± 0.8, respectively; P < 0.05) ( Table 2 ). Mean physical MacNew scores were 4.8 ± 1.0 in the group as a whole and were higher (P < 0.001) in patients with MI (5.1 ± 1.0) than in patients with either angina (4.4 ± 0.09) or heart failure (4.7 ± 1.0). There were no differences in emotional or social MacNew scores by diagnosis.
Short Form-36 Health Survey
Mean PCS scores were 41.1 ± 8.0 in the group as a whole and were higher (P < 0.001) in patients with MI (43.4 ± 7.8) than in patients with either angina (38.6 ± 6.6) or heart failure (39.2 ± 8.2). Although the MCS scores differed between the three diagnoses (P = 0.03), no significant post-hoc differences were observed.
Hospital Anxiety and Depression Scale
There were no differences by diagnosis for either anxiety or depression.
MacNew item characteristics
Missing item rates
In the total group, the missing MacNew item rate (excluding item #27, sexual activity) was always < 2.0% (item 24 = 1.9%); the missing rates were < 2.7% in patients with angina, < 1.4% in patients with MI and < 1.2% in patients with ischaemic heart failure. Of the 323 patients, seven patients (0.02%) missed four or more items, with one patient missing eight items, meaning that MacNew global scale and subscale scores could be calculated for each of the 323 patients.
Floor and ceiling effects
There were only minimal floor or ceiling effects for the mean MacNew physical scale in the total group (0.3%) and in patients with heart failure (1.1%) ( Table 3 ).
Factor analysis
With three MacNew subscales (i.e. physical, emotional and social), the original MacNew factor structure was confirmed for the French MacNew questionnaire, explaining 55.9% of the observed variance (physical = 24.8%, emotional = 17.4% and social = 13.7%) ( Table 4 ). Of the 31 factor loadings at ≥ 0.40 in the French MacNew questionnaire, 21 (68%) were fully consistent with the original MacNew factor structure, nine (29%) were partially consistent and only one (3%) was not consistent. Of the subscale items, three of the 13 physical items (23%), two of the 14 emotional items (14%) and five of the 13 social items (38%) did not load consistently with the original factor analysis.
Reliability
Internal consistency reliability (Cronbach's ␣) in the total group ranged from 0.89 to 0.94, with test-retest reliability (intraclass correlation coefficient) ranging from 0.68 to 0.73 (Table 3 ). In patients with angina, internal consistency reliability ranged from 0.86 to 0.93, with no test-retest reliability analysis as the sample size was too small (n = 11); in patients with MI, internal consistency reliability ranged from 0.89 to 0.95, with test-retest reliability ranging from 0.77 to 0.86; in patients with heart failure, internal consistency reliability ranged from 0.88 to 0.94, also with no test-retest reliability analysis as the number of patients was too small (n = 7).
Validity
Convergent validity
The convergent validity hypotheses for the MacNew questionnaire (i.e. strong correlations [r ≥ 0.50] between the MacNew physical subscale and the SF-36 PCS, and between the MacNew emotional subscale and the SF-36 MCS) were confirmed in the total group and each diagnosis, with r values ranging from 0.51 to 0.82, all significant at P < 0.01 ( Table 5 ). As hypothesized, the correlations between the MacNew emotional subscale and the SF-36 PCS were all less than strong and different in the total group and each diagnosis (P < 0.001). On the other hand, the correlations between the MacNew physical subscale and the SF-36 MCS were strong in the total group and in patients with either MI or heart failure, and were significantly different only in patients with MI.
Discriminative validity
Discriminative validity was confirmed for each of the predictor variables, SF-36 health transition, anxiety and depression in the total group, in patients with MI and in patients with heart failure, with MacNew score differences always significant at P < 0.001 (Table 6 ). In patients with angina, discriminative validity was confirmed only for anxiety and depression, again with score differences significant at P < 0.001. The difference in the MacNew scores between patients who perceived a deterioration in their health over the last year and those patient whose health had either improved or was unchanged over the last year always met or exceeded the MID of 0.50 points in the total group and in patients with MI or heart failure, but not in patients with angina. More consistently, the difference in MacNew scores between patients with and without anxiety and depression always met or exceeded the MID of 0.50 points in the total group and in each diagnosis group.
Discussion
The psychometric properties of the French MacNew HRQL questionnaire demonstrate that the instrument meets recommended reliability, validity and interpretability standards as a patient-reported outcome measure [17] , and is consistent with the recent report by the French Health Authority for French cardiologists and researchers [5] . An important advantage of the French MacNew questionnaire is that it has been validated in the three major IHD diagnoses (angina, MI and ischaemic heart failure). When used to compare HRQL after medical treatment, percutaneous coronary intervention (PCI) and coronary artery bypass graft, the Mac-New questionnaire demonstrated significant improvement in HRQL, differentiating the patterns of change between patients with continued medical treatment, PCI and coronary artery bypass graft [25] . Maes [26] . The original MacNew factor structure, with physical, emotional and social subscales, was largely confirmed with the French MacNew questionnaire, explaining 55.9% of the observed variance (physical variance explained = 24.8%, emotional = 17.4% and social = 13.7%). Using a factor loading threshold of > 0.40 as in the original factor structure analysis, more than two thirds of the items loaded consistently with the original factor structure [11] . However, 38% of the French MacNew social subscale items did not load consistently with the original factor analysis, which is consistent with similar proportions in the German [27] [28] [29] and Portuguese [30] , but not the Flemish [31] MacNew social subscales. The factor structure of the MacNew questionnaire is being further investigated at this time. The minimal missing data rate, never more than 2.7%, means that MacNew global scale and subscale scores could be calculated for each of the 323 patients. In addition, the absence of floor effects and the very low ceiling effects on only the emotional subscale (0.3% in the total group and 1.1% in patients with heart failure) allow measurement of both deterioration and improvement in patient-reported HRQL. Further, the items are relevant, it is easily interpreted and, with minimal missing item responses, overall the instrument is acceptable to the patients.
The French versions of the MacNew questionnaire, the SF-36 and the HADS, the latter two questionnaires previously validated in French [32, 33] , were completed by the patients in the French cohort recruited for the international HeartQoL Project [18] . As previously observed in other languages (e.g. English [14, 34] , Chinese [35] , Portuguese [30] and German [27, 29, 36] ), the French MacNew questionnaire has satisfactory reliability and validity. Internal consistency reliability is high and consistent with MacNew reports in other languages [26, 27, 29, 31, [34] [35] [36] , with Cronbach's ␣ ≥ 0.85 in the total group and in each diagnosis. Except for the MacNew social subscale in the total group, where testretest reliability was 0.68, the test reliability exceeded the criterion for group comparisons (≥ 0.70) in the total group and in patients with MI, but could not be determined in patients with angina or heart failure due to small sample sizes. Convergent validity of the French MacNew questionnaire was confirmed with strong correlations, ranging from 0.51 to 0.82, on all of the eight comparisons between similar MacNew and SF-36 scales (MacNew physical and SF-36 PCS; MacNew emotional and SF-36 MCS). As expected, the correlations between the MacNew emotional subscale and the SF-36 PCS were all significantly lower than between similar constructs [31, 34] . However, as has also been previously reported [27, 30, 31, 34] , the correlations between the Mac-New physical subscale and the SF-36 MCS were higher than expected in the total group as well as in patients with MI and heart failure. This may be a consequence of the differing perspectives taken in the MacNew and SF-36 questionnaires, particularly in terms of the physical items [27, 31] . The focus of the MacNew physical limitation probes is on how patients feel and perceive physical restrictions, while the focus of the SF-36 physical component probes is on how patients actually perform various physical tasks. The high correlations between the MacNew physical subscale and the SF-36 MCS may therefore reflect a perception of limitation in the MacNew questionnaire and a performance limitation in the SF-36 questionnaires.
Discriminative validity of the French MacNew questionnaire was partially confirmed on the SF-36 health transition item in the total group and in patients with either MI or with heart failure. However, by the SF-36 health transition category (i.e. between deterioration versus improved and/or no change compared with 1 year previously), all the statistically significant MacNew score differences, except for the MacNew global score in the total group of patients, met or exceeded the MID of 0.50 points on the 7-point Mac-New scale [22] . On the other hand, discriminative validity was fully confirmed for both anxiety and depression on the HADS. Differences in MacNew HRQL scores in patients with angina, MI or heart failure are related consistently to the presence or absence of anxiety and depression symptoms [28, 30, 31, 34, 35, 37] . Except for patients with angina, and then only for anxiety, MacNew scores were always higher in patients without anxiety or depression symptoms when compared with patients with symptoms, confirming previous reports in patients with angina, MI and heart failure [30, 31, 34, 35] . The differences were always significant and, except for the difference in patients with angina and symptoms of anxiety, they always met or exceeded the MID. Although follow-up data were not possible, given the crosssectional design of the parent HeartQoL Project, a recent publication has demonstrated that, in the 6 months following PCI, MacNew HRQL scores increase significantly and are negatively correlated with HADS scores [38] .
Study limitations
There are several limitations to the present validation of the French MacNew questionnaire. A major limitation is that prospective data were not available from the crosssectional study design of the HeartQoL Project, meaning that assessment of responsiveness, an important psychometric property of patient-reported outcome measures, was not possible. Maes et al., studying the Dutch version of MacNew questionnaire, showed adequate responsiveness in patients with MI with or without PCI, stable angina, heart failure, heart surgery or implantable cardioverter defibrillator, with significant improvement in the global scale and the three subscales in the total group and in each diagnosis over a 3-month cardiac rehabilitation intervention [26] . Another limitation is that the data were collected in a population of French-speaking patients with IHD who attended cardiac rehabilitation; however, this represents only 23% of the IHD population in France [39] ; this could explain the relatively 'young' age in the patients with heart failure, which is not atypical in heart failure populations in cardiac rehabilitation. Further investigations are therefore warranted in older French-speaking patients with ischaemic heart failure. When used to compare change in HRQL, the MacNew questionnaire demonstrated significant differences between patients with continued medical treatment, PCI and coronary artery bypass graft [38, 40] . The minimal missing data rate is a strength in this study, meaning that MacNew global and subscale scores could be calculated for each of the 323 patients. Although there are no prospective data, the absence of important subscale floor and ceiling effects is also a strength of the MacNew questionnaire, as it should permit measurement of HRQL change, both deterioration and improvement, in patient HRQL.
Conclusion
The French version of the MacNew HRQL questionnaire has been shown to be reliable and valid in French patients with the three major IHD diagnoses (angina, MI and heart failure) referred for cardiac rehabilitation. The MacNew questionnaire should permit measurement of disease-specific HRQL in patients undergoing interventions other than cardiac rehabilitation; this needs further investigation, as does responsiveness to change, which was not possible because of the cross-sectional design of the parent HeartQoL Project.
